UAMY grants RSUs and options to division president

United States Antimony Corp granted equity awards to John C. Gustavsen, its President, Antimony Division.

Rhea-AI Filing Summary

United States Antimony Corp granted equity awards to John C. Gustavsen, its President, Antimony Division. He received a restricted stock unit award covering 50,754 shares of Common Stock, vesting in three equal installments on January 15, 2026, January 15, 2027, and January 18, 2028, subject to continued service. He was also granted a stock option over 61.627 shares of Common Stock at an exercise price of $8.2900 per share, which vests upon achieving specified performance measures at any time during its 10-year term, also conditioned on continued service. These are compensation-related grants, not open-market purchases or sales.

Insider Trade Summary

Grant/Award: 50,815.627 shares

Grant/Award 2 txns

Insider Gustavsen John C.

Role President, Antimony Division

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,754	$0.00	$0.00
Grant/Award	Stock Option	61.627	$0.00	$0.00

Holdings After Transaction: Common Stock — 0 contracts (Direct); Stock Option — 0 contracts (Direct)

Footnotes (2)

1. F1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 16,918 shares of the 50,754 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.
2. F2. Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did UAMY report for John C. Gustavsen?

UAMY reported equity grants to John C. Gustavsen. He received a restricted stock unit award for 50,754 Common Stock shares and a stock option over 61.627 shares, both granted as compensation rather than open-market trades, under the company’s Amended & Restated 2023 Equity Incentive Plan.

How do John C. Gustavsen’s UAMY RSUs vest over time?

The RSU award vests in three equal installments. Of the 50,754 shares, 16,918 vest on January 15, 2026, another 16,918 on January 15, 2027, and the final 16,918 on January 18, 2028, all contingent on Gustavsen’s continued service with the company.

What are the key terms of John C. Gustavsen’s UAMY stock option grant?

The stock option covers 61.627 Common Stock shares. It has a conversion or exercise price of $8.2900 per share and can vest upon meeting specified performance measures at any time during its 10-year term, provided Gustavsen continues in service through any vesting date.

Is the UAMY Form 4 for John C. Gustavsen a stock purchase or sale?

The Form 4 reflects equity compensation grants, not trades. Both the 50,754-share RSU award and the 61.627-share stock option were granted at a price of $0.0000 per share, indicating awards under a compensation plan rather than open-market buying or selling.

Under which plan were John C. Gustavsen’s UAMY awards granted?

The awards were granted under UAMY’s Amended & Restated 2023 Equity Incentive Plan. Both the time-based restricted stock units and the performance-based stock option are issued pursuant to this plan, aligning Gustavsen’s compensation with the company’s long-term equity incentive structure.

What role does John C. Gustavsen hold at United States Antimony Corp?

John C. Gustavsen serves as President, Antimony Division. The Form 4 identifies him as an officer, not a director or 10% owner, and the reported RSU and stock option grants represent equity-based compensation tied to his ongoing service in this leadership role.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 07:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gustavsen John C.

(Last) (First) (Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS TEXAS 75209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Antimony Division

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(1)	$0.00	01/15/2026		A		50,754(1)		(1)	(1)	Common Stock	50.754	(1)	0(1)	D
Stock Option(2)	$8.29	01/15/2026		A		61.627(2)		(2)	(2)	Common Stock	61.627	(2)	0(2)	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 16,918 shares of the 50,754 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

	/s/ John C. Gustavsen	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)